Anti-FGFR3/CD333 Antibody (Vofatamab)
Catalog No.
F2043
Anti-FGFR3/CD333 Antibody (Vofatamab)
Featured Products
Vofatamab (B-701) is an anti-FGFR3 monoclonal antibody (mAb). Vofatamab blocks activation of both wild-type and genetically activated receptors. Vofatamab is being investigated in metastatic urothelial carcinoma (Muc).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
146.44 kDa
Dry ice
1312305-12-6
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
R3Mab, RG7444, MFGR1877S
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P22607
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human FGFR3IIIb His at 2 ug/mL can bind Anti-FGFR3/CD333 Antibody (Vofatamab)
FGFR3 / CD333
Please avoid freeze-thaw cycles.